Federation Des Caisses Desjardins Du Quebec Aptinyx Inc. Transaction History

Federation Des Caisses Desjardins Du Quebec

  • $18.9 Billion
  • Q3 2024

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 14, 2024
SELL
$0.06 - $0.14 $180 - $420
-3,000 Closed
0 $0
Q4 2022

Aug 14, 2024
SELL
$0.23 - $0.34 $1,610 - $2,380
-7,000 Reduced 70.0%
3,000 $855,000
Q1 2022

Aug 14, 2024
BUY
$2.27 - $3.62 $22,700 - $36,200
10,000 New
10,000 $22.7 Million
Q2 2021

Aug 30, 2024
BUY
$2.39 - $3.5 $23,900 - $35,000
10,000 New
10,000 $28.3 Million
Q1 2021

Aug 30, 2024
BUY
$2.86 - $4.33 $14,300 - $21,650
5,000 Added 100.0%
10,000 $30 Million
Q2 2020

Aug 30, 2024
BUY
$1.99 - $4.4 $9,950 - $22,000
5,000 New
5,000 $20.9 Million

About Aptinyx Inc.

APTX Quotes by TradingView
  • Ticker APTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 67,715,696
  • Description
  • Aptinyx Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of novel, proprietary, and synthetic small molecules for the treatment of brain and nervous system disorders. The company is developing NYX-2925, which is in Phase II clinical development for the treatment of painful diabetic pe...
More about APTX
Track This Portfolio

Track Federation Des Caisses Desjardins Du Quebec Portfolio

Follow Federation Des Caisses Desjardins Du Quebec and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Federation Des Caisses Desjardins Du Quebec, based on Form 13F filings with the SEC.

News

Stay updated on Federation Des Caisses Desjardins Du Quebec with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email